医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Theradome Inc. Accelerates Global Expansion Through Distribution Partnership in the Chinese Market

2015年10月09日 PM06:50
このエントリーをはてなブックマークに追加


 

PLEASANTON, Calif.

Theradome, Inc. recently named Nanjing XJS Ltd. as its master distributor of the Theradome™ laser hair regrowth helmet in the Chinese market.

Nanjing XJS Ltd., a distributor of several international high-end home-use medical devices in China, sells in hundreds of pharmacies, shops, hospitals and retail outlets throughout China. Through the partnership, the Theradome™ products will be featured in all those channels and Chinese online shopping channels.

Theradome, which has been a successful new product in USA, is sold at more than 200 Bosley Medical terminals. “The 678nm laser light used by Theradome stimulates the mitochondria at the base of the hair follicle, where the stem cells that grow hair are located,” Dr. Tamim Hamid, CEO and inventor of Theradome, explained the uniqueness of Theradome.

In the Chinese hair care market which boasts a market value of RMB 33.6 billion ($5.5 billion), sales of Western hair-loss treatments grew 90 percent from 2007 to 2012. Because of its size and growth rate, Theradome, Inc. attached great importance to the distribution in the Chinese market and regards it as an important step in its global expansion.

“There is a big market space for non-drug hair-loss therapy in China. Chinese people are losing confidence in functional shampoo and traditional Chinese medicines for hair loss. We could not be more excited about this opportunity to distribute Theradome in China and to work with such an innovative company. We are confident that Theradome will achieve great success in the Chinese market in the near future,” said Leo Chan, CEO of Nanjing XJS Ltd. “The Chinese leading-chain hair restoration hospitals will exhibit and resell Theradome soon.”

Theradome Inc. has also announced that Nanjing XJS Ltd. would be the distributor of the coming hair care supplements branding Theradome.

For more Chinese information about Theradome, please visit:

http://www.theradome.com.cn/

View source version on businesswire.com: http://www.businesswire.com/news/home/20151009005246/en/

CONTACT

Theradome Inc.
Travis Culver, +1 323-937-1951
press@theradome.com

同じカテゴリーの記事 

  • Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
  • 画期的な報告書により、高いニコチン消費量は健康問題の発生率を高めないことが証明される
  • 基于LC-Plasma的疫苗研究入选SCARDA项目
  • LC-Plasma-based Vaccine Research Selected for SCARDA Project
  • 一份具有里程碑意义的报告证明,大量使用尼古丁不会导致健康问题高发